中文 | English
Return
Total: 4 , 1/1
Show Home Prev Next End page: GO
Author:(Yuheng YAO)

1.Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function.

Yuheng JIN ; Xuxin QI ; Xiaoli YU ; Xirui CHENG ; Boya CHEN ; Mingfei WU ; Jingyu ZHANG ; Hao YIN ; Yang LU ; Yihui ZHOU ; Ao PANG ; Yushen LIN ; Li JIANG ; Qiuqiu SHI ; Shuangshuang GENG ; Yubo ZHOU ; Xiaojun YAO ; Linjie LI ; Haiting DUAN ; Jinxin CHE ; Ji CAO ; Qiaojun HE ; Xiaowu DONG

Acta Pharmaceutica Sinica B 2025;15(3):1659-1679

2.A prospective cohort study on reducing perioperative fasting in traumatic patients following Enhanced Recovery After Surgery protocol

Ting LI ; Yan ZHOU ; Xu SUN ; Zhijian SUN ; Yuheng JIANG ; Xuemei LU ; Guiling PENG ; Chunling ZHANG ; Yao JIANG ; Shengnan SUN ; Chen YI ; Yan AN ; Han WANG ; Bing HAN ; Geng WANG ; Xinbao WU

Chinese Journal of Orthopaedic Trauma 2018;20(4):312-317

3.Analysis of the Relevance between t-BHP Induced Apoptosis and STATs mRNA Expression in HEI-OC1 Cells

Zihao ZENG ; Xuan LUO ; Yuheng YAO ; Junyi WANG

Journal of Audiology and Speech Pathology 2018;26(2):162-166

4.Condition of human Th17 ceII differentiation induced in vitro

Chen WANG ; Wei GUO ; Xin WANG ; Dongmei YU ; Yuheng WANG ; Wenbing YAO

Journal of China Pharmaceutical University 2016;(1):106-111

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 4 , 1/1 Show Home Prev Next End page: GO